Tech Company Financing Transactions
Neupulse Funding Round
On 3/18/2024, Neupulse landed $3.2 million in Seed financing from Eos Advisory and private investors.
Transaction Overview
Company Name
Announced On
3/18/2024
Transaction Type
Venture Equity
Amount
$3,200,000
Round
Seed
Investors
Eos Advisory (Lead Investor)
Proceeds Purpose
The company intends to use the funds to advance its wearable device aimed at tackling Tourettes Syndrome (TS) and other tic disorders towards commercialization.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
The Ingenuity Centre University Of Nottingham Innovation Par
Nottingham, NG7 2TU
UK
Nottingham, NG7 2TU
UK
Phone
Undisclosed
Website
Email Address
Overview
Our research into the pathophysiology of Tourette syndrome and tic disorders dates back nearly two decades. During that time we have primarily used behavioural and state-of-the-art brain imaging and brain stimulation techniques to investigate: the neural processes that give rise to tics; the brain correlates of premonitory urges; and mechanisms of brain plasticity that might lead to the control or reduction of tics.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
James Duncan
Chief Executive Officer
Paul Cable
Chief Technical Officer
David Moser
VP - R & D
Barbara Morera
Browse more venture capital transactions:
Prev: 3/18/2024: QuantexAI venture capital transaction
Next: 3/18/2024: FlexPoint venture capital transaction
Share this article
Where The Data Comes From
We document all VC transactions involving tech companies. All VC database entries reported here are sourced from publicly available VC deal announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs